Gapping down
In reaction to disappointing earnings/guidance:
- RMD -14.4%, ASB -9.2%, INTC -6.9%, AVT -4.5%, ETFC -4.5%, NSC -4.1%, ISRG -3.8%, APD -3.2%, DFS -2.9%, ABBV -2.8%, CL -2.3%, ALK -1.9%, VOD -1%, DHI -0.8%, AYX -0.7%
Other news:
- CRBP -8.3% (to offer and sell shares of its common stock in an underwritten registered public offering)
- HSDT -8% (receives request for additional information letter from the FDA related to the Company's request for De Novo classification and 510(k) clearance of the Portable Neuromodulation Stimulator device)
- NVDA -1.5% (in sympathy with INTC)
Analyst comments:
- HA -2.5% (downgraded to Hold from Buy at Deutsche Bank)
- ILMN -1.7% (downgraded to Hold from Buy at Deutsche Bank)
- KBR -1.7% (downgraded to Hold from Buy at Deutsche Bank)
- PBF -1.2% (downgraded to Sell from Neutral at Goldman)
